Genomewide association study identifies no major founder variant in Caucasian moyamoya disease

Distribution of Moyamoya Disease Susceptibility Polymorphism p.R4810K in RNF213 in East and Southeast Asian Populations

(2015) Wanyang LIU et al.   NEUROLOGIA MEDICO-CHIRURGICA

Homozygous c.l4576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease

(2012) S. Miyatake et al.   NEUROLOGY

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population

(2012) Zhiyuan Wu et al.   PLoS One

Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

(2011) Wanyang Liu et al.   PLoS One

Analysis of ACTA2 in European Moyamoya disease patients

(2010) Constantin Roder et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease

(2009) Dong-Chuan Guo et al.   AMERICAN JOURNAL OF HUMAN GENETICS

ACTA2 is not a major disease-causing gene for moyamoya disease

(2009) Keiko Shimojima et al.   JOURNAL OF HUMAN GENETICS

A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians

(2009) Wanyang Liu et al.   Environmental Health and Preventive Medicine

Moyamoya disease: current concepts and future perspectives

(2008) Satoshi Kuroda et al.   LANCET NEUROLOGY